Statistical issues in bioequivalance
- 14 August 2001
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 20 (17-18) , 2785-2799
- https://doi.org/10.1002/sim.743
Abstract
There has been much work recently on individual bioequivalence and the topic has attracted considerable controversy. Some previous controversies regarding average bioequivalence are examined. It is argued that a contributory factor in these controversies may have been confusion over the purpose of bioequivalence trials. It is concluded that this purpose needs further clarification before guidelines for individual bioequivalence can be established and indeed that such guidelines may turn out to be unnecessary. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 21 references indexed in Scilit:
- Decision analysis and bioequivalence trialsStatistical Science, 1998
- An unbiased test for the bioequivalence problemThe Annals of Statistics, 1997
- Individual BioequivalenceClinical Pharmacokinetics, 1997
- Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilatorLife Sciences, 1993
- International Harmonization of Regulatory Bioequivalence RequirementsClinical Research and Regulatory Affairs, 1993
- On optimal tests for general interval-hypothesesCommunications in Statistics - Theory and Methods, 1993
- Consideration of individual bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1990
- General Approaches to the Problem of BioequivalenceJournal of the Royal Statistical Society: Series D (The Statistician), 1988
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987